(BIO) Bio-Rad Laboratories - Performance -10.2% in 12m
Compare BIO with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-55.51%
#32 in Group
Rel. Strength
29.69%
#5595 in Universe
Total Return 12m
-10.15%
#20 in Group
Total Return 5y
-48.76%
#27 in Group
P/E -
(?) Percentile in Group
P/E Forward 26.4
72th Percentile in Group
PEG 1.19
45th Percentile in Group
FCF Yield 4.36%
62th Percentile in Group
12m Total Return: BIO (-10.2%) vs XLV (-4.1%)
5y Drawdown (Underwater) Chart
Top Performers in Life Sciences Tools & Services
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| A NYSE Agilent Technologies |
9.48% | -23.3% | 38.3% | 24.9 | 19.3 | 1.76 | 60.8% | 7.8% |
| RVTY NYSE Revvity |
1.28% | -9.43% | 0.59% | 38.4 | 19.2 | 0.67 | -50.1% | -36.8% |
| QGEN NYSE Qiagen |
8.63% | -1.88% | -1.95% | 113 | 18.1 | 0.99 | -64.4% | -7.5% |
| SHC NASDAQ Sotera Health |
35% | 18% | -47.3% | 138 | 20.2 | 1.68 | -54.5% | -23.6% |
Performance Comparison: BIO vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for BIO
| Total Return (including Dividends) | BIO | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 9.30% | 0.87% | 13.81% |
| 3 Months | -26.31% | -7.96% | -6.30% |
| 12 Months | -10.15% | -4.06% | 10.65% |
| 5 Years | -48.76% | 43.49% | 107.77% |
| Trend Score (consistency of price movement) | BIO | XLV | S&P 500 |
| 1 Month | -47.5% | -8.1% | 83% |
| 3 Months | -86.5% | -75.3% | -75.3% |
| 12 Months | -18.5% | -28.8% | 50.1% |
| 5 Years | -83.2% | 89.7% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #28 | 8.36% | -3.96% |
| 3 Month | #37 | -19.9% | -21.4% |
| 12 Month | #20 | -6.35% | -18.8% |
| 5 Years | #28 | -64.3% | -75.3% |
FAQs
Does BIO Bio-Rad Laboratories outperforms the market?
No,
over the last 12 months BIO made -10.15%, while its related Sector, the Health Care Sector SPDR (XLV) made -4.06%.
Over the last 3 months BIO made -26.31%, while XLV made -7.96%.
Over the last 3 months BIO made -26.31%, while XLV made -7.96%.
Performance Comparison BIO vs Indeces and Sectors
BIO vs. Indices BIO is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.93% | -4.51% | -29.8% | -20.8% |
| US NASDAQ 100 | QQQ | -1.12% | -8.06% | -30.0% | -21.8% |
| US Dow Jones Industrial 30 | DIA | -1.34% | -0.69% | -29.5% | -17.9% |
| German DAX 40 | DAX | -0.91% | -5.66% | -56.1% | -35.9% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -3.11% | -2.53% | -30.6% | -17.5% |
| Hongkong Hang Seng | HSI | -4.10% | -10.6% | -38.2% | -23.8% |
| India NIFTY 50 | INDA | 3.99% | 4.46% | -30.2% | -9.94% |
| Brasil Bovespa | EWZ | -1.98% | -7.94% | -38.5% | -1.82% |
BIO vs. Sectors BIO is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.57% | -4.11% | -36.9% | -31.7% |
| Consumer Discretionary | XLY | -1.31% | -4.93% | -28.8% | -24.4% |
| Consumer Staples | XLP | -0.07% | 2.71% | -36.7% | -19.3% |
| Energy | XLE | -0.75% | 2.54% | -23.2% | -0.69% |
| Financial | XLF | -2.03% | -4.22% | -36.9% | -32.6% |
| Health Care | XLV | 2.08% | 8.43% | -24.8% | -6.09% |
| Industrial | XLI | -2.62% | -7.52% | -31.2% | -21.1% |
| Materials | XLB | -0.73% | -4.26% | -24.9% | -4.92% |
| Real Estate | XLRE | 0.39% | -2.24% | -30.5% | -25.6% |
| Technology | XLK | -2.01% | -11.9% | -26.9% | -17.3% |
| Utilities | XLU | -0.98% | -0.29% | -37.5% | -27.6% |
| Aerospace & Defense | XAR | -2.91% | -11.9% | -41.3% | -37.5% |
| Biotech | XBI | 5.66% | -2.51% | -9.65% | 2.14% |
| Homebuilder | XHB | -1.40% | -2.18% | -16.6% | -2.60% |
| Retail | XRT | -2.83% | -5.35% | -25.6% | -8.67% |